A case of bullous pemphigoid in a patient on hemodialysis

Journal of Dermatology

Volumn 25, Issue 4, 1998, Pages 246-249

  Kamada, Noriaki ^a   Ino, Noriaki ^a   Hatamochi, Atsushi ^a   Shinkai, Hiroshi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Bullous pemphigoid (BP); Chronic renal failure; Hemodialysis; Immune dysregulation

Indexed keywords

AGED; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; DISEASE ASSOCIATION; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; PATHOGENESIS; PEMPHIGOID;

EID: 0031978436     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1998.tb02390.x     Document Type: Article

References (13)

1. Goldsman CI, Taylor JS: Porphyria cutanea tarda and bullous dermatoses associated with chronic renal failure: A review, Cleve Clin Q, 50: 151-161, 1983.
2. Sato M, Terui T, Tabata N, Torinuki W, Takahashi H, Tagami H: Bullous pemphigoid masquerading as porphyria cutanea tarda in a patient on hemodialysis, Br J Dermatol, 129: 642-643, 1993.
3. Descamps-Latscha B, Herbelin A, Nguyen AT, et al: Balance between IL-1 β, TNF-α, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationship with activation markers of T cells, B cells, and monocytes, J Immunol, 154: 882-892, 1995.
4. Beaurain G, Naret C, Marcon L, et al: In vivo T cell activation in chronic uremic hemodialyzed and non-hemodialyzed patients, Kidney Int, 36: 636-644, 1989.
5. Gagnon RF, Shuster J, Kaye M: Auto-immunity in patients with end-stage renal disease maintained on hemodialysis and continuous ambulatory peritoneal dialysis, J Clin Lab Immunol, 11: 155-158, 1983.
6. Descamps-Latscha B, Chatenoud L: T cells and B cells in chronic renal failure, Semin Nephrol, 16: 183-191, 1996.
7. Lichtenstein JR, Babb EJ, Felsher BF: Porphyria cutanea tarda (PCT) in a patient with chronic renal failure on hemodialysis, Br J Dermatol, 104: 575-578, 1981.
8. Poh-Fitzpatrick MB, Bellet N, DeLeo VA, Grossman ME, Bickers DR: Porphyria cutanea tarda in two patients treated with hemodialysis for chronic renal failure, N Engl J Med, 299: 292-294, 1978.
9. Birkett DA, Garretts M, Stevenson CJ: Phototoxic bullous eruptions due to nalidixic acid, Br J Dermatol, 81: 342-344, 1969.
10. Burry JN, Lawrence JR: Phototoxic blisters from high frusemide dosage, Br J Dermatol, 94: 495-499, 1976.
11. Tamaki K, So K, Furuya T, Furue M: Cytokine profile of patients with bullous pemphigoid (letter), Br J Dermatol, 130: 128-129, 1994.
12. Maekawa N, Hosokawa H, Soh H, et al: Serum levels of soluble CD23 in patients with bullous pemphigoid, J Dermatol, 22: 310-315, 1995.
13. Descamps-Latscha B, Herbelin A, Nguyen AT, et al: Soluble CD23 as an effector of immune dysregulation in chronic uremia and dialysis, Kidney Int, 43: 878-884, 1993.